Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

USA - NYSE:CNK - US17243V1026 - Common Stock

28.25 USD
+0.08 (+0.28%)
Last: 9/12/2025, 8:04:00 PM
28.25 USD
0 (0%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNK. CNK was compared to 80 industry peers in the Entertainment industry. CNK has an excellent profitability rating, but there are concerns on its financial health. CNK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
CNK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNK reported negative net income in multiple years.
Of the past 5 years CNK 4 years had a positive operating cash flow.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a better Return On Assets (5.88%) than 83.75% of its industry peers.
CNK has a Return On Equity of 64.49%. This is amongst the best in the industry. CNK outperforms 98.75% of its industry peers.
The Return On Invested Capital of CNK (9.81%) is better than 86.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CNK is significantly below the industry average of 20.67%.
The last Return On Invested Capital (9.81%) for CNK is above the 3 year average (5.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROIC 9.81%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

CNK's Profit Margin of 8.98% is amongst the best of the industry. CNK outperforms 83.75% of its industry peers.
In the last couple of years the Profit Margin of CNK has grown nicely.
CNK has a Operating Margin of 12.82%. This is amongst the best in the industry. CNK outperforms 81.25% of its industry peers.
In the last couple of years the Operating Margin of CNK has remained more or less at the same level.
CNK has a better Gross Margin (64.08%) than 72.50% of its industry peers.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNK is still creating some value.
The number of shares outstanding for CNK has been increased compared to 1 year ago.
Compared to 5 years ago, CNK has more shares outstanding
CNK has a better debt/assets ratio than last year.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CNK has an Altman-Z score of 1.30. This is a bad value and indicates that CNK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.30, CNK is in line with its industry, outperforming 53.75% of the companies in the same industry.
CNK has a debt to FCF ratio of 8.05. This is a slightly negative value and a sign of low solvency as CNK would need 8.05 years to pay back of all of its debts.
CNK's Debt to FCF ratio of 8.05 is in line compared to the rest of the industry. CNK outperforms 60.00% of its industry peers.
CNK has a Debt/Equity ratio of 4.40. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 4.40, CNK is doing worse than 77.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Altman-Z 1.3
ROIC/WACC1.34
WACC7.3%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CNK may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.91, CNK is in line with its industry, outperforming 43.75% of the companies in the same industry.
CNK has a Quick Ratio of 0.91. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, CNK perfoms like the industry average, outperforming 46.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.88
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.66%, which is quite impressive.
CNK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.49% yearly.
CNK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.80%.
Measured over the past years, CNK shows a decrease in Revenue. The Revenue has been decreasing by -1.47% on average per year.
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%

3.2 Future

The Earnings Per Share is expected to grow by 7.71% on average over the next years.
CNK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.28% yearly.
EPS Next Y-23.88%
EPS Next 2Y4.69%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue Next Year7.27%
Revenue Next 2Y7.49%
Revenue Next 3Y6.49%
Revenue Next 5Y5.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.44, which indicates a correct valuation of CNK.
Compared to the rest of the industry, the Price/Earnings ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 87.50% of the companies listed in the same industry.
CNK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 12.70, the valuation of CNK can be described as correct.
Based on the Price/Forward Earnings ratio, CNK is valued cheaper than 90.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CNK to the average of the S&P500 Index (22.73), we can say CNK is valued slightly cheaper.
Industry RankSector Rank
PE 15.44
Fwd PE 12.7
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNK is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 7.83
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CNK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.44
EPS Next 2Y4.69%
EPS Next 3Y7.71%

3

5. Dividend

5.1 Amount

CNK has a Yearly Dividend Yield of 1.14%.
Compared to an average industry Dividend Yield of 12.43, CNK pays a better dividend. On top of this CNK pays more dividend than 87.50% of the companies listed in the same industry.
With a Dividend Yield of 1.14, CNK pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.14%

5.2 History

CNK has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y4.69%
EPS Next 3Y7.71%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (9/12/2025, 8:04:00 PM)

After market: 28.25 0 (0%)

28.25

+0.08 (+0.28%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners123.22%
Inst Owner Change0.62%
Ins Owners2.09%
Ins Owner Change-0.8%
Market Cap3.25B
Analysts77.65
Price Target34.17 (20.96%)
Short Float %22.86%
Short Ratio5.34
Dividend
Industry RankSector Rank
Dividend Yield 1.14%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.58%
Min EPS beat(2)-100.53%
Max EPS beat(2)-14.63%
EPS beat(4)1
Avg EPS beat(4)-4.7%
Min EPS beat(4)-100.53%
Max EPS beat(4)109.69%
EPS beat(8)4
Avg EPS beat(8)57.72%
EPS beat(12)6
Avg EPS beat(12)21.99%
EPS beat(16)7
Avg EPS beat(16)0.74%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-0.41%
Revenue beat(4)2
Avg Revenue beat(4)0.86%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)9
Avg Revenue beat(12)2.59%
Revenue beat(16)12
Avg Revenue beat(16)2.59%
PT rev (1m)-0.25%
PT rev (3m)1.24%
EPS NQ rev (1m)-9.87%
EPS NQ rev (3m)-21.66%
EPS NY rev (1m)-10.53%
EPS NY rev (3m)-7.15%
Revenue NQ rev (1m)-2.05%
Revenue NQ rev (3m)-7.04%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 15.44
Fwd PE 12.7
P/S 1.01
P/FCF 10.66
P/OCF 7.06
P/B 7.26
P/tB N/A
EV/EBITDA 7.83
EPS(TTM)1.83
EY6.48%
EPS(NY)2.22
Fwd EY7.88%
FCF(TTM)2.65
FCFY9.38%
OCF(TTM)4
OCFY14.17%
SpS27.97
BVpS3.89
TBVpS-9.54
PEG (NY)N/A
PEG (5Y)3.44
Profitability
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROCE 11.34%
ROIC 9.81%
ROICexc 13.19%
ROICexgc 30.77%
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
FCFM 9.47%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Debt/EBITDA 3.23
Cap/Depr 79.01%
Cap/Sales 4.84%
Interest Coverage 2.98
Cash Conversion 75.53%
Profit Quality 105.54%
Current Ratio 0.91
Quick Ratio 0.88
Altman-Z 1.3
F-Score6
WACC7.3%
ROIC/WACC1.34
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
EPS Next Y-23.88%
EPS Next 2Y4.69%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%
Revenue Next Year7.27%
Revenue Next 2Y7.49%
Revenue Next 3Y6.49%
Revenue Next 5Y5.28%
EBIT growth 1Y52.76%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year74.83%
EBIT Next 3Y28.22%
EBIT Next 5Y16.59%
FCF growth 1Y40.92%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y35.07%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%